Spyre Therapeutics
SYRE
#4930
Rank
C$2.01 B
Marketcap
$34.28
Share price
3.16%
Change (1 day)
42.32%
Change (1 year)

EPS for Spyre Therapeutics (SYRE)

EPS in 2024 (TTM): -$96.12

According to Spyre Therapeutics's latest financial reports the company's current EPS (TTM) is -$103.71. In 2023 the company made an earnings per share (EPS) of -$70.57 a decrease over its 2022 EPS that were of -$35.56.

EPS history for Spyre Therapeutics from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-$96.1236.2%
2023-$70.5798.46%
2022-$35.56-1%
2021-$35.92-34.21%
2020-$54.60-37.96%
2019-$88.0015.02%
2018-$76.5118.33%
2017-$64.66-18.92%
2016-$79.74120.2%
2015-$36.21-33.55%
2014-$54.50